Patent Assignment
Reel/Frame 010197/0519
Merger and Change of Name
Recorded: 1999-08-30
Pages: 6
Assignor
ONCOGENE SCIENCE, INC.
Executed: 1997-09-26
Assignee
OSI PHARMACEUTICALS, INC.
106 CHARLES LINDBERGH BLVD., UNIONDALE, NEW YORK, 11553
Covered Properties
(34)
Monoclonal Antibodies Reactive with Normal and Oncogenic Forms of the Ras P21 Protein
Patent:
5,081,230 →
Application:
07/071,175 →
Monoclonal Antibodies Reactive with Activated and Oncogenic Ras P21 Proteins
Patent:
4,898,932 →
Application:
07/111,315 →
Monoclonal Antibodies Against Activated Ras Proteins with Amino Acid Mutations at Position 13 of the Protein
Patent:
5,028,527 →
Application:
07/158,730 →
Monoclonal Antibodies Recognizing Parathyroid Hormone - Like Protein
Patent:
5,217,896 →
Application:
07/292,263 →
Monoclonal Antibodies Directed to Epitopes of Human Transforming Growth Factor - Alpha and Uses Thereof
Patent:
5,190,858 →
Application:
07/304,947 →
Monoclonal Antibodies Reactive with Activated and Oncogenic Ras P21 Proteins
Patent:
5,084,380 →
Application:
07/428,381 →
A Method for Obtaining Bone Marrow Free of Tumor Cells Using Transforming Growth Factor-B3
Patent:
5,262,319 →
Application:
07/543,341 →
Antibodies Reactive with Normal and Oncogenic Forms of the Ras P21 Protein
Patent:
5,262,523 →
Application:
07/800,052 →
Detection and Quantification of Neu Related Proteins in the Biological Fluids of Humans
Patent:
5,401,638 →
Application:
07/806,112 →
Methods of Determining Chemicals That Modulate Expression of Genes Associated with Cardiovascular Disease
Patent:
5,580,722 →
Application:
07/832,905 →
Detection, Quantitation and Classification of Ras Proteins in Body Fluids and Tissues
Patent:
5,443,956 →
Application:
08/078,485 →
Immunoassay for Detection of Mutant P53 Polypeptide in Serum
Patent:
6,083,709 →
Application:
08/094,071 →
Tissue-Derived Tumor Growth Inhibitors, Methods of Preparation and Uses Thereof
Patent:
5,824,297 →
Application:
08/115,519 →
Tissue-Derived Tumor Growth Inhibitors
Patent:
6,586,394 →
Application:
08/188,197 →
Detection of Neu P185 in Cell Lysates
Patent:
5,604,107 →
Application:
08/220,962 →
Methods of Preparing Compositions Comprising Chemicals Capable of Transcriptional Modulation
Patent:
6,203,976 →
Application:
08/255,236 →
Method of Discovering Chemicals Capable of Functioning as Gene Expression Modulators
Patent:
5,665,543 →
Application:
08/267,834 →
Tissue-Derived Tumor Growth Inhibitors, Methods of Preparation and Uses Thereof
Patent:
6,559,123 →
Application:
08/294,061 →
Detection and Quantification of Neu Related Proteins in the Biological Fluids of Humans
Application:
08/321,179 →
Methods of Prevention of Oral Mucositis with Transforming Growth Factor Beta
Patent:
5,817,625 →
Application:
08/370,227 →
Methods of Prevention of Oral Mucositis with Transforming Growth Factor Beta
Patent:
5,635,489 →
Application:
08/395,909 →
Detection, Quantitation and Classification of Ras Proteins in Body Fluids and Tissues
Patent:
6,200,764 →
Application:
08/425,885 →
Tissue-Derived Tumor Growth Inhibitors, Methods of Preparation and Uses Thereof
Patent:
6,425,769 →
Application:
08/457,097 →
Methods of Transcriptionally Modulating Gene Expression
Patent:
5,776,502 →
Application:
08/458,691 →
Methods of Preparing Compositions Comprising Chemicals Capable of Transcriptional Modulation
Patent:
6,589,733 →
Application:
08/463,398 →
Methods of Transcriptionally Modulating Expression of Viral Genes and Genes Useful for Production of Proteins
Patent:
6,165,712 →
Application:
08/463,691 →
Tissue-Derived Tumor Growth Inhibitors, Methods of Preparation and Uses Thereof
Patent:
5,871,724 →
Application:
08/476,014 →
Detection and Quantification of Neu Related Proteins in the Biological Fluids of Humans
Patent:
6,861,511 →
Application:
08/488,180 →
Methods of Transcriptionally Modulating Gene Expression and of Discovering Chemicals Capable of Functioning as Gene Expression Modulators
Patent:
5,976,793 →
Application:
08/683,455 →
Methods of Determining Chemicals That Modulate Expression of Genes Associated with Cardiovascular Disease
Patent:
5,846,720 →
Application:
08/700,757 →
Methods of Specifically Transcriptionally Modulating the Expression of a Gene of Interest
Patent:
6,136,779 →
Application:
08/778,754 →
Methods of Transcriptionally Modulating Gene Expression and of Discovering Chemicals Capable of Functioning as Gene Expression Modulators
Patent:
5,863,733 →
Application:
08/779,230 →
Methods of Transcriptionally Modulating Gene Expression
Application:
09/047,966 →
Publication:
US 2003/0138773
Methods of Discovering Chemicals Capable of Functioning as Gene Expression Modulators
Patent:
6,376,175 →
Application:
09/123,728 →
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Dec 31, 1987
From: CARNEY, WALTER P.
To: E.I. DU PONT DE NEMOURS AND COMPANY, WILMINGTON, DELAWARE, A CORP. OF DE
Reel/Frame 004815/0408 →
Assignment of Assignors Interest.
Jul 6, 1988
From: CARNEY, WALTER PATRICK
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 004909/0770 →
Assignment of Assignors Interest.
Mar 14, 1989
From: VALENZUELA, DAVID M.; REYNOLDS, FREDERICK H. JR; SORVILLO, JOHN M.
To: ONCOGENE SCIENCE, INC.
Reel/Frame 005041/0887 →
Assignment of Assignors Interest.
May 1, 1989
From: SORVILLO, JOHN M.; VALENZUELA, DAVID M.; REYNOLDS, FREDERICK H. JR.
To: ONOCOGENE SCIENCE, INC., A CORP. OF DE
Reel/Frame 005067/0818 →
Assignment of Assignors Interest.
Nov 1, 1990
From: IWATA, KENNETH K.; FOULKES, J. GORDON; DIJKE, PETER T.; HALEY, JOHN D.
To: ONCOGENE SCIENCE, INC., A CORP. OF DE
Reel/Frame 005517/0430 →
Assignment of Assignors Interest.
Apr 10, 1991
From: E. I. DU PONT DE NEMOURS AND COMPANY, A CORP. OF DE
To: APPLIED BIOTECHNOLOGY, A CORP. OF MA
Reel/Frame 005660/0772 →
Security Interest
Apr 25, 1991
From: APPLIED BIOTECHNOLOGY, INC., A CORP. OF DE
To: E. I. DU PONT DE NEMOURS AND COMPANY
Reel/Frame 005681/0470 →
Assignment of Assignors Interest.
Mar 9, 1992
From: E.I. DU PONT DE NEMOURS AND COMPANY A CORP. OF DELAWARE
To: APPLIED BIOTECHNOLOGY, INC. A CORP. OF DELAWARE
Reel/Frame 006034/0874 →
Assignment of Assignors Interest.
Mar 26, 1992
From: APPLIED BIOTECHNOLOGY, INC. A CORP. OF DELAWARE
To: ONCOGENE SCIENCE, INC. A CORP. OF DELAWARE
Reel/Frame 006054/0923 →
Assignment of Assignors Interest.
May 4, 1992
From: FOULKES, J. GORDON; LIECHTFRIED, FRANZ E.; PIELER, CHRISTIAN; STEPHENSON, JOHN R.
To: ONCOGENE SCIENCE, INC., A DELAWARE CORPORATION
Reel/Frame 006107/0504 →
Assignment of Assignors Interest.
May 26, 1992
From: E. I. DU PONT DE NEMOURS AND COMPANY
To: APPLIED BIOTECHNOLOGY, INC.
Reel/Frame 006135/0642 →
Assignment of Assignors Interest.
Dec 18, 1992
From: KRAMER, STEVEN P.; VALENZUELA, DAVID M.; REYNOLDS, FREDERICK H., JR.; SORVILLO, JOHN M.
To: ONCOGENE SCIENCE, INC.
Reel/Frame 006359/0846 →
Assignment of Assignor's Interest
Nov 3, 1993
From: IWATA, KENNETH K.; FOULKES, J. GORDON; DIJKE, PETER TEN; HALEY, JOHN D.
To: ONCOGENE SCIENCE, INC.
Reel/Frame 006748/0348 →
Assignment of Assignor's Interest
Dec 29, 1993
From: REYNOLDS, FREDERICK H., JR.; ZEHEB, RON; STEPHENSON, JOHN R.; SORVILLO, JOHN M.
To: ONCOGENE SCIENCE, INC.
Reel/Frame 006818/0400 →
Assignment of Assignor's Interest
Apr 5, 1994
From: IWATA, KENNETH K.; STEPHENSON, JOHN R.; GOLD, LESLIE I.
To: ONCOGENE SCIENCE INC.
Reel/Frame 006934/0715 →
Assignment of Assignor's Interest
Nov 4, 2002
From: IWATA, KENNETH K.; STEPHENSON, JOHN R.; GOLD, LESLIE I
To: ONCOGENE SCIENCE, INC.
Reel/Frame 013469/0930 →
Change of Address
Apr 6, 2004
From: OSI PHARMACEUTICALS, INC.
To: OSI PHARMACEUTICALS, INC.
Reel/Frame 015147/0743 →
Assignment of Assignor's Interest
Jun 18, 2010
From: BAYER CORPORATION
To: SIEMENS HEALTHCARE DIAGNOSTICS INC.
Reel/Frame 024555/0519 →
Assignment of Assignor's Interest
Jun 18, 2010
From: OSI PHARMACEUTICALS, INC.
To: BAYER CORPORATION
Reel/Frame 024555/0513 →